Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study
Clinical trial NCT05896748 · COMPLETED
Trial details
- NCT number
- NCT05896748
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2023-09-14
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.